National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
    Cancer Studies Highlighted in the NCI Cancer Bulletin  
 
Page Options
Print This Page
E-Mail This Document
Search by Cancer Type
Breast Cancer

Colon and Rectal Cancer

Lung Cancer

Prostate Cancer

More Featured Trials
Search Featured Trials

      
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
You Can Quit Smoking Now!
Related Pages
Search for Clinical Trials
NCI's PDQ® registry of cancer clinical trials.

Childhood Cancers Home Page
NCI's gateway for information about pediatric cancers.
Childhood Cancers - Featured Clinical Trials

The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:

1.  New Strategy for Treatment-Resistant Solid Tumors in Children
(Posted: 06/13/2006) - This clinical trial will assess the safety of of a drug called talabostat in combination with chemotherapy in pediatric patients with cancer who have not responded to or gotten worse after other treatments.

2.  Chemotherapy for Recurrent or Treatment-Resistant Lymphomas
(Posted: 07/26/2005) - In this trial, researchers are trying to determine whether a new drug called UCN-01 will help kill cancer cells in patients who have a type of lymphoma called anaplastic large cell lymphoma.

3.  Treating Mouth Sores in Pediatric Chemotherapy Patients
(Posted: 12/14/2004) - This trial is testing a homeopathic mouth rinse as a treatment for mucositis in young patients undergoing chemotherapy in preparation for stem cell transplantation.

4.  Treatment to Slow Tumor Progression in Children with Neurofibromatosis Type 1
(Posted: 10/26/2004) - Researchers are testing the drug tipifarnib in children with neurofibromatosis type I to see if it will slow progression of plexiform neurofibromas.


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov